Loading...
Loading...
Burning Rock Biotech Ltd
Burning Rock Biotech Ltd. Spoken Alpha tracks BNR's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks BNR's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 9/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BNR.
curl https://api.spokenalpha.com/v1/companies/BNR| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $0.54 | $0.61 | -10.9% | -1.5% | -2.2% |
| Q4 FY2026 | $0.73 | $0.76 | -3.9% | -0.6% | -0.1% |
| Q3 FY2026 | $0.77 | $0.81 | -4.9% | +2.6% | +5.1% |
| Q2 FY2026 | $0.56 | $0.65 | -13.8% | +4.2% | +6.6% |
| Q1 FY2025 | $0.60 | $0.70 | -13.7% | +1.1% | -0.4% |
| Q4 FY2025 | $0.75 | $0.76 | -1.6% | -7.5% | -9.9% |
| Q3 FY2025 | $0.90 | $0.90 | 0.0% | +2.7% | +2.9% |
| Q2 FY2025 | $0.74 | $0.75 | -1.1% | -0.6% | -1.0% |
| Q1 FY2024 | $0.71 | $0.74 | -4.2% | -2.2% | -1.8% |
| Q4 FY2024 | $0.72 | $0.77 | -7.0% | -2.9% | -5.1% |